BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24667721)

  • 21. Family-based associations in measures of psychological distress and quality of life in a cardiac screening clinic for inheritable cardiac diseases: a cross-sectional study.
    McGorrian C; McShane C; McQuade C; Keelan T; Neill JO; Galvin J; Malone K; Mahon NG; Codd M
    BMC Med Genet; 2013 Jan; 14():1. PubMed ID: 23295100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anxiety and depression in oncology patients; a longitudinal study of a screening, assessment and psychosocial support intervention.
    Thalén-Lindström A; Larsson G; Glimelius B; Johansson B
    Acta Oncol; 2013 Jan; 52(1):118-27. PubMed ID: 22934559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flourishing or floundering? Prevalence and correlates of anxiety and depression among a population-based sample of adult cancer survivors 6months after diagnosis.
    Boyes AW; Girgis A; D'Este C; Zucca AC
    J Affect Disord; 2011 Dec; 135(1-3):184-92. PubMed ID: 21864913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The suitability of the Hospital Anxiety and Depression Scale, Distress Thermometer and other instruments to screen for psychiatric disorders in both lung cancer patients and their partners.
    Schellekens MPJ; van den Hurk DGM; Prins JB; Molema J; van der Drift MA; Speckens AEM
    J Affect Disord; 2016 Oct; 203():176-183. PubMed ID: 27295374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detecting depressive and anxiety disorders in distressed patients in primary care; comparative diagnostic accuracy of the Four-Dimensional Symptom Questionnaire (4DSQ) and the Hospital Anxiety and Depression Scale (HADS).
    Terluin B; Brouwers EP; van Marwijk HW; Verhaak P; van der Horst HE
    BMC Fam Pract; 2009 Aug; 10():58. PubMed ID: 19698153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Self-reported distress and problems after treatment for gynecological cancer - Correlation between a short screening tool and longer measures of anxiety/depression and health-related quality of life.
    Skaali T; Blomhoff R; Lindemann K; Smeland S; Bruheim K; Seland M; Thorsen L
    Acta Obstet Gynecol Scand; 2024 Feb; 103(2):387-395. PubMed ID: 37991142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A psychometric evaluation of the Hospital Anxiety and Depression Scale in patients diagnosed with end-stage renal disease.
    Martin CR; Tweed AE; Metcalfe MS
    Br J Clin Psychol; 2004 Mar; 43(Pt 1):51-64. PubMed ID: 15005906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychosocial distress and utilization of professional psychological care in cancer patients: An observational study in National Comprehensive Cancer Centers (CCCs) in Germany.
    Weis J; Hönig K; Bergelt C; Faller H; Brechtel A; Hornemann B; Stein B; Teufel M; Goerling U; Erim Y; Geiser F; Niecke A; Senf B; Wickert M; Schmoor C; Gerlach A; Schellberg D; Büttner-Teleaga A; Schieber K
    Psychooncology; 2018 Dec; 27(12):2847-2854. PubMed ID: 30276915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for depression and anxiety in childhood neurogenic bladder dysfunction.
    Kabra AT; Feustel PJ; Kogan BA
    J Pediatr Urol; 2015 Apr; 11(2):75.e1-7. PubMed ID: 25824880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Symptoms and diagnosis of anxiety and depression in atopic dermatitis in U.S. adults.
    Silverberg JI; Gelfand JM; Margolis DJ; Boguniewicz M; Fonacier L; Grayson MH; Ong PY; Chiesa Fuxench ZC; Simpson EL
    Br J Dermatol; 2019 Sep; 181(3):554-565. PubMed ID: 30838645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid screening for depression--validation of the Brief Case-Find for Depression (BCD) in medical oncology and palliative care patients.
    Jefford M; Mileshkin L; Richards K; Thomson J; Matthews JP; Zalcberg J; Jennens R; McLachlan SA; Wein S; Antill Y; Clarke DM
    Br J Cancer; 2004 Aug; 91(5):900-6. PubMed ID: 15305199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the Hospital Anxiety and Depression Scale (HADS) in screening stroke patients for symptoms: Item Response Theory (IRT) analysis.
    Ayis SA; Ayerbe L; Ashworth M; DA Wolfe C
    J Affect Disord; 2018 Mar; 228():33-40. PubMed ID: 29202444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychometric properties of the Danish Hospital Anxiety and Depression Scale in patients with cardiac disease: results from the DenHeart survey.
    Christensen AV; Dixon JK; Juel K; Ekholm O; Rasmussen TB; Borregaard B; Mols RE; Thrysøe L; Thorup CB; Berg SK
    Health Qual Life Outcomes; 2020 Jan; 18(1):9. PubMed ID: 31910859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Symptom distress in advanced cancer patients with anxiety and depression in the palliative care setting.
    Delgado-Guay M; Parsons HA; Li Z; Palmer JL; Bruera E
    Support Care Cancer; 2009 May; 17(5):573-9. PubMed ID: 19005686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distress Screening in Adolescents and Young Adults with Cancer: Development of Cut-Points for the Cancer Distress Scales-Adolescent and Young Adults.
    Rae C; Klassen AF; Tsangaris E; Breakey V; D'Agostino N
    J Adolesc Young Adult Oncol; 2019 Oct; 8(5):560-565. PubMed ID: 31219363
    [No Abstract]   [Full Text] [Related]  

  • 36. The Basic Documentation for Psycho-Oncology Short Form (PO-Bado SF)--an expert rating scale for distress screening: development and psychometric properties.
    Marten-Mittag B; Book K; Buchhold B; Dinkel A; Gründobler B; Henrich G; Huber B; Pirker C; Regenberg A; Schickel S; Senf B; Wünsch A; Herschbach P
    Psychooncology; 2015 Jun; 24(6):653-60. PubMed ID: 25346529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using Rasch analysis to examine the distress thermometer's cut-off scores among a mixed group of patients with cancer.
    Lambert SD; Pallant JF; Clover K; Britton B; King MT; Carter G
    Qual Life Res; 2014 Oct; 23(8):2257-65. PubMed ID: 24687566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Edmonton Symptom Assessment System (ESAS) as a screening tool for depression and anxiety in non-advanced patients with solid or haematological malignancies on cure or follow-up.
    Ripamonti CI; Bandieri E; Pessi MA; Maruelli A; Buonaccorso L; Miccinesi G
    Support Care Cancer; 2014 Mar; 22(3):783-93. PubMed ID: 24276952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An introduction to the Rasch measurement model: an example using the Hospital Anxiety and Depression Scale (HADS).
    Pallant JF; Tennant A
    Br J Clin Psychol; 2007 Mar; 46(Pt 1):1-18. PubMed ID: 17472198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is the Hospital Anxiety and Depression Scale (HADS) a valid measure in a general population 65-80 years old? A psychometric evaluation study.
    Djukanovic I; Carlsson J; Årestedt K
    Health Qual Life Outcomes; 2017 Oct; 15(1):193. PubMed ID: 28978356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.